These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30994011)

  • 21. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia.
    Arega B; Menbere F; Getachew Y
    BMC Infect Dis; 2019 Apr; 19(1):307. PubMed ID: 30947695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Airways delivery of rifampicin microparticles for the treatment of tuberculosis.
    Suarez S; O'Hara P; Kazantseva M; Newcomer CE; Hopfer R; McMurray DN; Hickey AJ
    J Antimicrob Chemother; 2001 Sep; 48(3):431-4. PubMed ID: 11533012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rifampicin determination in plasma by stir bar-sorptive extraction and liquid chromatography.
    Balbão MS; Bertucci C; Bergamaschi MM; Queiroz RH; Malfará WR; Dreossi SA; de Paula Mello L; Queiroz ME
    J Pharm Biomed Anal; 2010 Apr; 51(5):1078-83. PubMed ID: 20005065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin.
    Hartkoorn RC; Khoo S; Back DJ; Tjia JF; Waitt CJ; Chaponda M; Davies G; Ardrey A; Ashleigh S; Ward SA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):76-82. PubMed ID: 17643357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization and Validation of a Chromatographic Method for the Quantification of Isoniazid in Urine of Tuberculosis Patients According to the European Medicines Agency Guideline.
    Mishra P; Albiol-Chiva J; Bose D; Durgbanshi A; Peris-Vicente J; Carda-Broch S; Esteve-Romero J
    Antibiotics (Basel); 2018 Dec; 7(4):. PubMed ID: 30545003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
    Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 infection and risk of tuberculosis after rifampicin treatment.
    Corbett EL; Mallory KF; Grant AD; Churchyard GJ; De Cock KM
    Lancet; 2001 Mar; 357(9260):957-8. PubMed ID: 11289372
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G
    J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):151-4. PubMed ID: 18486058
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients at 5 Mexican public hospitals.
    Alvarado-Esquivel C; Rossau R; Martínez-García S; Cisneros-Martínez JA; Mijs W; Nevárez-Nájera A; Fierro-Campa R; Mercado-Suárez MF; Hernández-Campos S; Chacón-Arciniega R; Vázquez J; Saucedo-Martínez G; Ruiz-Astorga R
    Rev Invest Clin; 2001; 53(6):526-30. PubMed ID: 11921525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin.
    Alsayyed B
    Pediatr Rev; 2004 Jun; 25(6):216-7. PubMed ID: 15173456
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of four months of rifampicin in the treatment of latent tuberculosis infection.
    Davies P; Ormerod P
    Am J Respir Crit Care Med; 2005 Aug; 172(4):509; author reply 509-10. PubMed ID: 16081559
    [No Abstract]   [Full Text] [Related]  

  • 33. The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.
    Chen C; Ortega F; Rullas J; Alameda L; Angulo-Barturen I; Ferrer S; Simonsson US
    J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):133-141. PubMed ID: 28205025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    Cynamon M; Sklaney MR; Shoen C
    J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically significant interactions with drugs used in the treatment of tuberculosis.
    Yew WW
    Drug Saf; 2002; 25(2):111-33. PubMed ID: 11888353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of rifampicin on antihypertensive effects of dihydropiridine calcium-channel blockers in four elderly patients].
    Yoshimoto H; Takahashi M; Saima S
    Nihon Ronen Igakkai Zasshi; 1996 Sep; 33(9):692-6. PubMed ID: 8940868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
    Mqoqi NP; Churchyard GA; Kleinschmidt I; Williams B
    S Afr Med J; 1997 Nov; 87(11):1517-21. PubMed ID: 9472274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
    Abate G; Mshana RN; Miörner H
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):1011-6. PubMed ID: 9869118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of FASTPlaqueTB-RIF, a rapid, manual test for the determination of rifampicin resistance from Mycobacterium tuberculosis cultures.
    Albert H; Heydenrych A; Mole R; Trollip A; Blumberg L
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):906-11. PubMed ID: 11605883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages.
    Tukulula M; Gouveia L; Paixao P; Hayeshi R; Naicker B; Dube A
    Pharm Res; 2018 Mar; 35(6):111. PubMed ID: 29600438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.